clobenpropit has been researched along with Breast Neoplasms in 1 studies
clobenpropit: histamine H3 receptor antagonist
clobenpropit : An imidothiocarbamic ester that consists of isothiourea bearing S-3-(imidazol-4-yl)propyl and N-4-chlorobenzyl substituents. An extremely potent histamine H3 antagonist/inverse agonist (pA2 = 9.93). Also displays partial agonist activity at H4 receptors; induces eosinophil shape change with an EC50 of 3 nM.
Breast Neoplasms: Tumors or cancer of the human BREAST.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Medina, V | 1 |
Croci, M | 1 |
Crescenti, E | 1 |
Mohamad, N | 1 |
Sanchez-Jiménez, F | 1 |
Massari, N | 1 |
Nuñez, M | 1 |
Cricco, G | 1 |
Martin, G | 1 |
Bergoc, R | 1 |
Rivera, E | 1 |
1 other study available for clobenpropit and Breast Neoplasms
Article | Year |
---|---|
The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment.
Topics: Adult; Aged; Breast; Breast Neoplasms; Cell Movement; Cell Proliferation; Female; Histamine; Histidi | 2008 |